Error processing SSI file

Immunization and Infectious Diseases

Healthy People 2010 Objective Details

Immunization and Infectious Diseases Focus Area documents
Focus Area	Objective
14- Immunization and Infectious Diseases	14-01a – Vaccine-preventable diseases – Congenital rubella syndrome (number of cases, children under 1 year)
14- Immunization and Infectious Diseases	14-01b – Vaccine-preventable diseases – Diphtheria (number of cases, aged under 35 years)
14- Immunization and Infectious Diseases	14-01c – Vaccine-preventable diseases – Haemophilus influenza type b and unknown – Children – (number of cases, aged under 5 years)
14- Immunization and Infectious Diseases	14-01d – Vaccine-preventable diseases – Hepatitis B (number of cases, aged 2 to 18 years)
14- Immunization and Infectious Diseases	14-01e – Vaccine-preventable diseases – Measles (number of cases)
14- Immunization and Infectious Diseases	14-01f – Vaccine-preventable diseases – Mumps (number of cases)
14- Immunization and Infectious Diseases	14-01g – Vaccine-preventable diseases – Pertussis – Children (number of cases, aged under 7 years)
14- Immunization and Infectious Diseases	14-01h – Vaccine-preventable diseases – Polio (wild-type virus) (number of cases)
14- Immunization and Infectious Diseases	14-01i – Vaccine-preventable diseases – Rubella (number of cases)
14- Immunization and Infectious Diseases	14-01j – Vaccine-preventable diseases – Tetanus (number of cases, aged under 35 years)
14- Immunization and Infectious Diseases	14-01k – Vaccine-preventable diseases – Varicella (chicken pox) – (annual average number of cases (thousands), aged 17 years and under)
14- Immunization and Infectious Diseases	14-02 – Hepatitis B in infants and young children – Perinatal infections (number of cases, aged 1 to 24 months)
14- Immunization and Infectious Diseases	14-03a – Hepatitis B in adults and high-risk groups – Adults (cases per 100,000 population, aged 19 to 24 years)
14- Immunization and Infectious Diseases	14-03b – Hepatitis B in adults and high-risk groups – Adults (cases per 100,000 population, aged 25 to 39 years)
14- Immunization and Infectious Diseases	14-03c – Hepatitis B in adults and high-risk groups – Adults (cases per 100,000 population, aged 40 years and over)
14- Immunization and Infectious Diseases	14-03d – Hepatitis B in adults and high-risk groups – High-risk groups – Injection drug users (number of cases)
14- Immunization and Infectious Diseases	14-03e – Hepatitis B in adults and high-risk groups – High-risk groups – Heterosexually active persons (number of cases)
14- Immunization and Infectious Diseases	14-03f – Hepatitis B in adults and high-risk groups – High-risk groups – Men who have sex with men (number of cases)
14- Immunization and Infectious Diseases	14-03g – Hepatitis B in adults and high-risk groups – High-risk groups – Occupationally exposed workers (number of cases)
14- Immunization and Infectious Diseases	14-04 – Bacterial meningitis in young children (new cases per 100,000 population, aged 1 to 23 months)
14- Immunization and Infectious Diseases	14-05a – Invasive pneumococcal infections – Children (new cases per 100,000 population, aged under 5 years)
14- Immunization and Infectious Diseases	14-05b – Invasive pneumococcal infections – Adults (new cases per 100,000 population, aged 65 years and over)
14- Immunization and Infectious Diseases	14-05c – Invasive pneumococcal infections – Penicillin-resistant – Children (new cases per 100,000 population, aged under 5 years)
14- Immunization and Infectious Diseases	14-05d – Invasive pneumococcal infections – Penicillin-resistant – Adults (new cases per 100,000 population, aged 65 years and over)
14- Immunization and Infectious Diseases	14-06 – Hepatitis A – (new cases per 100,000 population)
14- Immunization and Infectious Diseases	14-07 – Meningococcal disease – (new cases per 100,000 population)
14- Immunization and Infectious Diseases	14-08 – Lyme disease – In endemic States – (5-year average annual new cases per 100,000 population)
14- Immunization and Infectious Diseases	14-09 – Hepatitis C – new cases (per 100,000 population)
14- Immunization and Infectious Diseases	14-10 – States reporting chronic HCV infection (number of States)
14- Immunization and Infectious Diseases	14-11 – Tuberculosis – new cases (per 100,000 population)
14- Immunization and Infectious Diseases	14-12 – Curative therapy for tuberculosis
14- Immunization and Infectious Diseases	14-13 – Treatment for high-risk persons with latent tuberculosis infection
14- Immunization and Infectious Diseases	14-14 – Timely laboratory confirmation of tuberculosis cases – Average number of days to report 75% of cases
14- Immunization and Infectious Diseases	14-15 – Prevention services for international travelers [Deleted at Midcourse Review]
14- Immunization and Infectious Diseases	14-16 – Invasive early onset group B streptococcal disease (per 1,000 live births)
14- Immunization and Infectious Diseases	14-17 – Peptic ulcer hospitalizations (age adjusted per 100,000 standard population)
14- Immunization and Infectious Diseases	14-18 – Antibiotics prescribed for ear infections – Children (courses prescribed per 100 population, aged under 5 years)
14- Immunization and Infectious Diseases	14-19 – Antibiotics prescribed for common cold (annual average number of courses prescribed per 100,000 population)
14- Immunization and Infectious Diseases	14-20a – Hospital-acquired infections – Adult intensive care patients – Catheter-associated urinary tract infection (per 1,000 days use)
14- Immunization and Infectious Diseases	14-20b – Hospital-acquired infections – Adult intensive care patients – Central line-associated bloodstream infection (per 1,000 days use)
14- Immunization and Infectious Diseases	14-20c – Hospital-acquired infections – Adult intensive care patients – Ventilator-associated pneumonia (per 1,000 days use)
14- Immunization and Infectious Diseases	14-20d – Hospital-acquired infections – Infants weighing 1000 grams or less at birth in intensive care – Central line-associated bloodstream infection (per 1,000 days use)
14- Immunization and Infectious Diseases	14-20e – Hospital-acquired infections – Infants weighing 1000 grams or less at birth in intensive care – Ventilator-associated pneumonia (per 1,000 days use)
14- Immunization and Infectious Diseases	14-21 – Antimicrobial use in intensive care units (daily doses per 1,000 patient days)
14- Immunization and Infectious Diseases	14-22a – Universally recommended vaccination of children aged 19 to 35 months – 4 doses diphtheria-tetanus-acellular pertussis (DtaP) vaccine
14- Immunization and Infectious Diseases	14-22b – Universally recommended vaccination of children aged 19 to 35 months – 3 doses Haemophilus influenza type b (Hib) vaccine
14- Immunization and Infectious Diseases	14-22c – Universally recommended vaccination of children aged 19 to 35 months – 3 doses hepatitis B (hep B) vaccine
14- Immunization and Infectious Diseases	14-22d – Universally recommended vaccination of children aged 19 to 35 months – 1 dose measles-mumps-rubella (MMR) vaccine
14- Immunization and Infectious Diseases	14-22e – Universally recommended vaccination of children aged 19 to 35 months – 3 doses polio vaccine
14- Immunization and Infectious Diseases	14-22f – Universally recommended vaccination of children aged 19 to 35 months – 1 dose varicella vaccine
14- Immunization and Infectious Diseases	14-22g – Universally recommended vaccination of children aged 19 to 35 months – 4 doses pneumococcal conjugate vaccine [New]
14- Immunization and Infectious Diseases	14-22h – Universally recommended vaccination of children aged 6 to 23 months – 1 dose influenza vaccine [New]
14- Immunization and Infectious Diseases	14-23a – Diphtheria-tetanus-acellular pertussis (DtaP) vaccine coverage, children in day care
14- Immunization and Infectious Diseases	14-23b – Measles-mumps-rubella (MMR) vaccine coverage, children in day care
14- Immunization and Infectious Diseases	14-23c – Polio vaccine coverage, children in day care
14- Immunization and Infectious Diseases	14-23d – Hepatitis B vaccine coverage, children in day care
14- Immunization and Infectious Diseases	14-23e – Varicella vaccine coverage, children in day care
14- Immunization and Infectious Diseases	14-23f – Diphtheria-tetanus-acellular pertussis (DtaP) vaccine coverage, children in kindergarten
14- Immunization and Infectious Diseases	14-23g – Measles-mumps-rubella (MMR) vaccine coverage, children in kindergarten
14- Immunization and Infectious Diseases	14-23h – Polio vaccine coverage, children in kindergarten
14- Immunization and Infectious Diseases	14-23i – Hepatitis B vaccine coverage, children in kindergarten
14- Immunization and Infectious Diseases	14-23j – Varicella vaccine coverage, children in kindergarten
14- Immunization and Infectious Diseases	14-23k – Pneumococcal conjugate vaccine coverage, children in daycare [New]
14- Immunization and Infectious Diseases	14-23l – Maintain vaccination coverage levels for children in licensed day care facilities – Haemophilus influenzae type b vaccine [New]
14- Immunization and Infectious Diseases	14-24a – Fully immunized young children and adolescents – Children aged 19 to 35 months
14- Immunization and Infectious Diseases	14-24b – Fully immunized young children and adolescents – Adolescents aged 13 to 15 years
14- Immunization and Infectious Diseases	14-25a – Providers who measure childhood vaccination coverage levels – Public health providers
14- Immunization and Infectious Diseases	14-25b – Providers who measure childhood vaccination coverage levels – Private providers
14- Immunization and Infectious Diseases	14-26 – Children participating in population-based immunization registries (aged under 6 years)
14- Immunization and Infectious Diseases	14-27a – Vaccination coverage among adolescents – 3 or more doses of hepatitis B (aged 13 to 15 years)
14- Immunization and Infectious Diseases	14-27b – Vaccination coverage among adolescents – 2 or more doses of measles, mumps, rubella (aged 13 to 15 years)
14- Immunization and Infectious Diseases	14-27c – Vaccination coverage among adolescents – 1 or more doses of tetanus-diptheria booster (aged 13 to 15 years)
14- Immunization and Infectious Diseases	14-27d – Vaccination coverage among adolescents – 1 or more doses of varicella (excluding adolescents who have varicella) (aged 13 to 15 years)
14- Immunization and Infectious Diseases	14-28a – Hepatitis B vaccination among high-risk groups – Long-term hemodialysis patients
14- Immunization and Infectious Diseases	14-28b – Hepatitis B vaccination among high-risk groups – Men who have sex with men
14- Immunization and Infectious Diseases	14-28c – Hepatitis B vaccination among high-risk groups – Occupationally exposed workers
14- Immunization and Infectious Diseases	14-29a – Influenza and pneumococcal vaccination of high-risk adults – Noninstitutionalized adults – Influenza vaccine in the past 12 months (age adjusted, aged 65 years and over)
14- Immunization and Infectious Diseases	14-29b – Influenza and pneumococcal vaccination of high-risk adults – Noninstitutionalized adults – Pneumococcal vaccine ever received (age adjusted, aged 65 years and over)
14- Immunization and Infectious Diseases	14-29c – Influenza and pneumococcal vaccination of high-risk adults – Noninstitutionalized high-risk adults – Influenza vaccine in the past 12 months (age adjusted, aged 18 to 64 years)
14- Immunization and Infectious Diseases	14-29d – Influenza and pneumococcal vaccination of high-risk adults – Noninstitutionalized high-risk adults – Pneumococcal vaccine ever received (age adjusted, aged 18 to 64 years)
14- Immunization and Infectious Diseases	14-29e – Influenza and pneumococcal vaccination of high-risk adults – Institutionalized – Influenza vaccine in the past 12 months (aged 18 years and over)
14- Immunization and Infectious Diseases	14-29f – Influenza and pneumococcal vaccination of high-risk adults – Institutionalized – Pneumococcal vaccine ever received (aged 18 years and over)
14- Immunization and Infectious Diseases	14-29g – Influenza and pneumococcal vaccination of high-risk adults – Health care workers – Influenza vaccine in the past 12 months (aged 18 to 64 years) [New]
14- Immunization and Infectious Diseases	14-30a – Adverse events from vaccinations – Associated paralytic polio (number)
14- Immunization and Infectious Diseases	14-30b – Adverse events from vaccinations – Febrile seizures caused by pertussis vaccines (number)
14- Immunization and Infectious Diseases	14-31a – Active surveillance for vaccine safety via large linked databases (number (millions))
14- Immunization and Infectious Diseases	14-31b – Total VAERS reports submitted electronically [New]

Top of Page

Error processing SSI file